Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Department of Respiration, Shanghai Central Hospital, Shanghai, China.
BMC Pulm Med. 2022 Jul 1;22(1):261. doi: 10.1186/s12890-022-02038-3.
While asthma comorbidities are associated with higher health care utilisation, lower quality of life and poorer asthma control, the impact of asthma comorbidities on hospitalisation for asthma exacerbation (H-AX) remains less recognised. We aim to analyse the impact of asthma comorbidities on H-AX.
Based on a national survey on asthma control and disease perception (CARN 2015 study), we analysed the impact of comorbidities on annual incidence and frequency of H-AX in China. Information on demographic characteristics, asthma comorbidities and annual incidence and frequency of H-AX were presented in this study.
Among 3875 ambulatory asthma patients, 75.9% (2941/3875) had comorbidities, and 26.4% (1017/3858) experienced H-AX during past year. After adjusting for confounding factors such as demographic data, smoking status and asthma control, COPD [OR = 2.189, 95% CI (1.673, 2.863)] and coronary heart disease [OR = 1.387, 95% CI (1.032, 1.864)] were associated with higher annual incidence, while allergic rhinitis [OR = 0.692, 95% CI (0.588, 0.815)] was associated with lower annual incidence, of H-AX. In terms of frequency, allergic rhinitis [OR = 1.630, 95% CI (1.214, 2.187)], COPD [OR = 1.472, 95% CI (1.021, 2.122)] and anxiety [OR = 2.609, 95% CI (1.051, 6.477)] showed statistically significant correlation with frequent H-AX.
COPD and coronary heart disease were associated with higher annual incidence, while allergic rhinitis was associated with lower annual incidence of H-AX. Allergic rhinitis, COPD and anxiety were associated with frequent H-AX. Comorbidities may have an important role in the risk and frequency of annual hospitalisations due to asthma exacerbation. The goal of asthma control should rely on a multi-disciplinary treatment protocol.
虽然哮喘合并症与更高的医疗保健利用率、更低的生活质量和更差的哮喘控制相关,但哮喘合并症对哮喘加重住院(H-AX)的影响仍未得到充分认识。我们旨在分析哮喘合并症对 H-AX 的影响。
基于一项关于哮喘控制和疾病认知的全国性调查(CARN 2015 研究),我们分析了合并症对中国哮喘患者 H-AX 年发生率和频率的影响。本研究介绍了人口统计学特征、哮喘合并症以及 H-AX 的年发生率和频率信息。
在 3875 名门诊哮喘患者中,75.9%(2941/3875)有合并症,26.4%(1017/3858)在过去一年中经历过 H-AX。在调整了人口统计学数据、吸烟状况和哮喘控制等混杂因素后,COPD[比值比(OR)=2.189,95%置信区间(CI)(1.673,2.863)]和冠心病(OR=1.387,95%CI(1.032,1.864)]与较高的年发生率相关,而过敏性鼻炎(OR=0.692,95%CI(0.588,0.815)]与较低的年发生率相关。就频率而言,过敏性鼻炎(OR=1.630,95%CI(1.214,2.187)]、COPD(OR=1.472,95%CI(1.021,2.122)]和焦虑(OR=2.609,95%CI(1.051,6.477)]与频繁 H-AX 呈统计学显著相关。
COPD 和冠心病与较高的年发生率相关,而过敏性鼻炎与较低的年发生率相关。过敏性鼻炎、COPD 和焦虑与频繁的 H-AX 相关。合并症可能在哮喘加重导致的年度住院风险和频率中发挥重要作用。哮喘控制的目标应依赖于多学科治疗方案。